Epifanio Sànchez-Garavito

Statistics

Publications

Citations

783

H-Index

Active since

2012

Affiliations

Universidad Privada Sergio Bernales(Current)

State Education Development Agency

Université de Montpellier

University of Cape Town

EsSALUD

Epifanio Sànchez-Garavito is an author at Universidad Privada Sergio Bernales specializing in tuberculosis care, tuberculosis pharmacotherapy, and tuberculosis control.

Publications per year

2012–2025

Publications

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

Maria Tarcela Gler, Vija Skripconoka, Epifanio Sànchez-Garavito et al. · New England Journal of Medicine · 2012 · 737 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial

Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez et al. · The Lancet Respiratory Medicine · 2025 · 24 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Nine-month, all-oral regimens for rifampin-resistant tuberculosis

Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez et al. · medRxiv · 2024 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis

Thelma E. Tupasi, Rajesh Gupta, Manfred Danilovitš et al. · Bulletin of the World Health Organization · 2015 · 10 citations · Full text

Medicine, Pharmacology, Drug Approval Processes +16

1–4 of 4